Jena, June 15, 2010, SIRS-Lab GmbH and Analytik Jena AG, also based in Jena, will be strengthened by working together in the field of molecular sepsis diagnostics. As part of this cooperation, Analytik Jena subsidiary AJ Innuscreen GmbH will provide the partner with a platform for automated isolation of nucleic acids with the associated reagent system worth almost half a million euro.
more »

Jena, August 12, 2009 SIRS-Lab GmbH, the molecular diagnostics company focused on sepsis and life threatening infections, has elected Barbara Staehelin as new Chief Executive Officer.
more »

London, Jena, May 7, 2009 The Frost & Sullivan “2009 European Molecular Diagnostics for Infectious Diseases Product Line Strategy of the Year Award”, is presented to SIRS-Lab GmbH.
more »

Jena, February 4, 2009 SIRS-Lab, a leader in molecular diagnostics, is delighted to announce the appointment of Dr. Edward Currie as Executive Vice-President, Corporate Development.
more »

Jena, December 11, 2008 SIRS-Lab is pleased to announce the appointment of Ania Mitan as Executive Vice President Commercial.
more »

Jena, December 3, 2008 SIRS-Lab today announced that the EU regulatory authorities have granted the CE mark for VYOO, a molecular diagnostic test for pathogen detection in sepsis. With VYOO, clinicians can rapidly and reliably identify causative pathogens as well as important antibiotic resistance markers.
more »